Metlife Stock Performance
| MET Stock | USD 86.44 1.25 1.47% |
On a scale of 0 to 100, MetLife holds a performance score of 11. The company secures a Beta (Market Risk) of 1.4, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, MetLife will likely underperform. Please check MetLife's potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether MetLife's current price movements will revert.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in MetLife are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating technical and fundamental indicators, MetLife unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.57 | Five Day Return 4.97 | Year To Date Return 28.47 | Ten Year Return 72.53 | All Time Return 558.48 |
Forward Dividend Yield 0.0256 | Payout Ratio 0.2723 | Last Split Factor 1122:1000 | Forward Dividend Rate 2.18 | Dividend Date 2024-12-16 |
1 | Acquisition by Johnson Jeh C. of 627 shares of MetLife at 69.86 subject to Rule 16b-3 | 09/06/2024 |
| MetLife dividend paid on 10th of September 2024 | 09/10/2024 |
2 | Acquisition by Robert Hubbard of 918 shares of MetLife at 81.78 subject to Rule 16b-3 | 10/01/2024 |
3 | Acquisition by Ramy Tadros of 28113 shares of MetLife at 69.16 subject to Rule 16b-3 | 10/22/2024 |
4 | Pierre Fabre announce 1st Patient Dosed in Phase III of PFL-002VERT-002, a targeted therapy in NSCLC with MET Alterations | 10/24/2024 |
5 | Why It Might Not Make Sense To Buy MetLife, Inc. For Its Upcoming Dividend | 10/31/2024 |
6 | Amalgamated Bank Sells 4,088 Shares of MetLife, Inc. | 11/06/2024 |
7 | Acquisition by Catherine Kinney of 594 shares of MetLife subject to Rule 16b-3 | 11/07/2024 |
8 | TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS | 11/08/2024 |
9 | 4,482 Shares in MetLife, Inc. Acquired by Carlton Hofferkamp Jenks Wealth Management LLC | 11/13/2024 |
10 | MetLife Named to the Fortune Worlds 25 Best Workplaces for 2024 | 11/14/2024 |
11 | Thrivent Financial for Lutherans Acquires 1,446 Shares of MetLife, Inc. | 11/18/2024 |
12 | MetLife, Inc. Receives Average Rating of Buy from Brokerages | 11/19/2024 |
13 | The Most Wonderful Time Of The Year - Seasonal Factors Favor Stocks | 11/21/2024 |
| Begin Period Cash Flow | 20.2 B |
MetLife |
MetLife Relative Risk vs. Return Landscape
If you would invest 7,422 in MetLife on August 24, 2024 and sell it today you would earn a total of 1,097 from holding MetLife or generate 14.78% return on investment over 90 days. MetLife is generating 0.228% of daily returns assuming volatility of 1.59% on return distribution over 90 days investment horizon. In other words, 14% of stocks are less volatile than MetLife, and above 96% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
MetLife Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MetLife's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MetLife, and traders can use it to determine the average amount a MetLife's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1434
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MET | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.59 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average MetLife is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MetLife by adding it to a well-diversified portfolio.
MetLife Fundamentals Growth
MetLife Stock prices reflect investors' perceptions of the future prospects and financial health of MetLife, and MetLife fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MetLife Stock performance.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0058 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 71.41 B | |||
| Shares Outstanding | 692.42 M | |||
| Price To Earning | 28.61 X | |||
| Price To Book | 1.85 X | |||
| Price To Sales | 0.83 X | |||
| Revenue | 66.9 B | |||
| Gross Profit | 14.89 B | |||
| EBITDA | 3.92 B | |||
| Net Income | 1.6 B | |||
| Cash And Equivalents | 20.2 B | |||
| Cash Per Share | 41.28 X | |||
| Total Debt | 18.83 B | |||
| Debt To Equity | 4.11 % | |||
| Current Ratio | 1.11 X | |||
| Book Value Per Share | 44.52 X | |||
| Cash Flow From Operations | 13.72 B | |||
| Earnings Per Share | 4.93 X | |||
| Market Capitalization | 58.99 B | |||
| Total Asset | 687.58 B | |||
| Retained Earnings | 40.15 B | |||
About MetLife Performance
Assessing MetLife's fundamental ratios provides investors with valuable insights into MetLife's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the MetLife is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Capital Employed | 0.10 | 0.08 | |
| Return On Equity | 0.05 | 0.09 |
Things to note about MetLife performance evaluation
Checking the ongoing alerts about MetLife for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MetLife help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 75.0% of the company shares are owned by institutional investors | |
| Latest headline from forbes.com: The Most Wonderful Time Of The Year - Seasonal Factors Favor Stocks |
- Analyzing MetLife's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MetLife's stock is overvalued or undervalued compared to its peers.
- Examining MetLife's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MetLife's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MetLife's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MetLife's stock. These opinions can provide insight into MetLife's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for MetLife Stock Analysis
When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.